Literature DB >> 24009174

Tregs, HSCT, and acute GVHD: up close and personal.

John Koreth1, Jerome Ritz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24009174      PMCID： PMC3765054          DOI： 10.1182/blood-2013-07-514125

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.

Authors:  Katayoun Rezvani; Stephan Mielke; Mojgan Ahmadzadeh; Yasemin Kilical; Bipin N Savani; Josette Zeilah; Keyvan Keyvanfar; Aldemar Montero; Nancy Hensel; Roger Kurlander; A John Barrett
Journal:  Blood       Date:  2006-04-20       Impact factor: 22.113

Review 2.  Development and maintenance of regulatory T cells.

Authors:  Naganari Ohkura; Yohko Kitagawa; Shimon Sakaguchi
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

3.  Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.

Authors:  Ken-ichi Matsuoka; Haesook T Kim; Sean McDonough; Gregory Bascug; Ben Warshauer; John Koreth; Corey Cutler; Vincent T Ho; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

4.  Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

Authors:  Kathrin Rieger; Christoph Loddenkemper; Jochem Maul; Thomas Fietz; Daniel Wolff; Harald Terpe; Beate Steiner; Erika Berg; Stephan Miehlke; Martin Bornhäuser; Thomas Schneider; Martin Zeitz; Harald Stein; Eckhard Thiel; Rainer Duchmann; Lutz Uharek
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

5.  Interleukin-2 and regulatory T cells in graft-versus-host disease.

Authors:  John Koreth; Ken-ichi Matsuoka; Haesook T Kim; Sean M McDonough; Bhavjot Bindra; Edwin P Alyea; Philippe Armand; Corey Cutler; Vincent T Ho; Nathaniel S Treister; Don C Bienfang; Sashank Prasad; Dmitrios Tzachanis; Robin M Joyce; David E Avigan; Joseph H Antin; Jerome Ritz; Robert J Soiffer
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

6.  Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

Authors:  Emmanuel Zorn; Haesook T Kim; Stephanie J Lee; Blair H Floyd; Despina Litsa; Sankari Arumugarajah; Roberto Bellucci; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

7.  Human regulatory T cells in allogeneic stem cell transplantation.

Authors:  Sya N Ukena; Sarvari Velaga; Robert Geffers; Jens Grosse; Udo Baron; Stefanie Buchholz; Michael Stadler; Dunja Bruder; Arnold Ganser; Anke Franzke
Journal:  Blood       Date:  2011-07-21       Impact factor: 22.113

8.  Association of Foxp3 regulatory gene expression with graft-versus-host disease.

Authors:  Yuji Miura; Christopher J Thoburn; Emilie C Bright; Michele L Phelps; Tahiro Shin; Elizabeth C Matsui; William H Matsui; Sally Arai; Ephraim J Fuchs; Georgia B Vogelsang; Richard J Jones; Allan D Hess
Journal:  Blood       Date:  2004-06-01       Impact factor: 22.113

9.  Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease.

Authors:  Shen Dong; Sylvie Maiella; Aliénor Xhaard; Yuanyu Pang; Lynn Wenandy; Jérome Larghero; Christophe Becavin; Arndt Benecke; Elisabetta Bianchi; Gérard Socié; Lars Rogge
Journal:  Blood       Date:  2013-07-01       Impact factor: 22.113

10.  Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease.

Authors:  Ken-ichi Matsuoka; John Koreth; Haesook T Kim; Gregory Bascug; Sean McDonough; Yutaka Kawano; Kazuyuki Murase; Corey Cutler; Vincent T Ho; Edwin P Alyea; Philippe Armand; Bruce R Blazar; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Journal:  Sci Transl Med       Date:  2013-04-03       Impact factor: 17.956
  10 in total
  8 in total

Review 1.  Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases.

Authors:  Kevin Hendrawan; Malini Visweswaran; David D F Ma; John J Moore
Journal:  Bone Marrow Transplant       Date:  2019-10-16       Impact factor: 5.483

Review 2.  Umbilical cord blood graft engineering: challenges and opportunities.

Authors:  P A Thompson; K Rezvani; C M Hosing; B Oran; A L Olson; U R Popat; A M Alousi; N D Shah; S Parmar; C Bollard; P Hanley; P Kebriaei; L Cooper; J Kellner; I K McNiece; E J Shpall
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

3.  Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).

Authors:  Mahasweta Gooptu; Haesook T Kim; Alan Howard; Sung W Choi; Robert J Soiffer; Joseph H Antin; Jerome Ritz; Corey S Cutler
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-02       Impact factor: 5.742

4.  Human Amniotic Mesenchymal Stem Cells Inhibit aGVHD by Regulating Balance of Treg and T Effector Cells.

Authors:  Ya Gao; Weiru Li; Xiaoyin Bu; Ying Xu; Shengchun Cai; Jinman Zhong; Meixue Du; Haitao Sun; Liping Huang; Yongjian He; Xiumei Hu; Qifa Liu; Hua Jin; Qian Wang; Baohong Ping
Journal:  J Inflamm Res       Date:  2021-08-16

5.  Conformal Nanoencapsulation of Allogeneic T Cells Mitigates Graft-versus-Host Disease and Retains Graft-versus-Leukemia Activity.

Authors:  Shuting Zhao; Lingling Zhang; Jianfeng Han; Jianhong Chu; Hai Wang; Xilin Chen; Youwei Wang; Norm Tun; Lanchun Lu; Xue-Feng Bai; Martha Yearsley; Steven Devine; Xiaoming He; Jianhua Yu
Journal:  ACS Nano       Date:  2016-05-31       Impact factor: 15.881

6.  Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft-versus-host disease: A pilot study.

Authors:  Acf Motta; Q Zhan; A Larson; M Lerman; S-B Woo; R J Soiffer; G F Murphy; N S Treister
Journal:  Oral Dis       Date:  2018-03-13       Impact factor: 3.511

7.  The Role of the Ikaros Family of Transcription Factors in Regulatory T cell Development and Function.

Authors:  Amara Seng; Thomas M Yankee
Journal:  J Clin Cell Immunol       Date:  2017-03-22

8.  The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis.

Authors:  Ja Min Byun; Hea-Lim Kim; Dong-Yeop Shin; Youngil Koh; Sung-Soo Yoon; Moon-Woo Seong; Sung Sup Park; Jin Hee Kim; Yun-Gyoo Lee; Inho Kim
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.